Press release
Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR)
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/request-sample/59
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก: The growth of the market is driven by factors such as the increasing prevalence of chronic kidney diseases, the rise in the number of cancer patients undergoing chemotherapy, and the growing geriatric population.
๐๐ฒ๐ฉ๐๐ฌ ๐จ๐ ๐๐ซ๐ฒ๐ญ๐ก๐ซ๐จ๐ฉ๐จ๐ข๐๐ญ๐ข๐ง ๐๐ซ๐ฎ๐ ๐ฌ: The two major types of erythropoietin drugs are biosimilars and biologics. Biosimilars are expected to dominate the market due to their cost-effectiveness compared to biologics.
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ซ๐๐๐ฌ: Erythropoietin drugs are primarily used in the treatment of anemia caused by chronic kidney disease, cancer, and other diseases. They are also used to reduce the need for blood transfusions during surgeries.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ: North America held the largest share of the market in 2020, followed by Europe and Asia Pacific. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
On the basis product type, epoetin-alfa segment is anticipated to grow with the highest revenue throughout the forecast period, owing to increase in sales of Epogen, which is the top selling brand of erythropoietin, developed by Amgen. Epogen indicated notable growth in the U.S. market as Amgen procured patent protection for this product.
By application, the kidney disorders (ESRD and Dialysis) segment accounted for a major share in 2020, and is expected to exhibit a prominent growth rate during the forecast period, owing to increase in cases of patients with kidney disease. Furthermore, ESRD is majorly responsible for prescription of EPO treatment among renal disease patients.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง -
https://www.alliedmarketresearch.com/request-for-customization/59
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
AMGEN INC.
JOHNSON AND JOHNSON
ROCHE DIAGNOSTICS
HOSPIRA INC.
LG LIFE SCIENCES LTD.
BIOCON
INTAS PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES LTD.
RANBAXY LABORATORIES LTD.
CELLTRION, INC
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/checkout-final/fbeb76f67944772a3785fb1c960404e6
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Browse more latest healthcare reports:
๐๐จ๐ฉ๐ข๐๐๐ฅ ๐๐ฑ๐ฒ๐ ๐๐ง ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/topical-oxygen-therapy-market-A16966
๐๐๐ฆ๐จ๐ฌ๐ญ๐๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/hemostats-market-A16840
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐จ๐ง ๐๐ง๐ข๐ฆ๐๐ฅ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/companion-animal-diagnostics-market-A11127
๐๐๐๐ข๐จ๐ฌ๐ฎ๐ซ๐ ๐๐ซ๐ฒ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.alliedmarketresearch.com/radiosurgery-systems-market-A14841
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market 2023 Update - Projected Revenue Surges to USD 14.41 Billion by 2028, Boasting a 5.7% Compound Annual Growth Rate (CAGR) here
News-ID: 3334610 • Views: โฆ
More Releases from allied market research
Sustainable Tourism Market Size Worth USD 11.4 trillion By 2032 | Growth Opportu โฆ
According to a new report published by Allied Market Research, titled, "Sustainable Tourism Market" The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. In 2023, the coastal tourism segment occupied the largest market share as it is one of the most popular types of sustainable tourism locations in the world due toโฆ
Dermocosmetics Market is slated to increase at a CAGR of 11.1% to reach a valuat โฆ
The global Dermocosmetics market size was valued at $51.10 billion in 2021, and is projected to reach $130.46 billion by 2030, growing at a CAGR of 11.1% from 2022 to 2030. The Dermocosmetics Market report defines and outlines the products, applications, and specifications to the reader. The study lists the leading companies operating in the Market and highlights the key change processes that companies have adopted to maintain their strengths.โฆ
Vegan Cosmetics Market is slated to increase at a CAGR of 5.9% to reach a valuat โฆ
According to a new report published by Allied Market Research, titled, "Vegan Cosmetics Market," The vegan cosmetics market size was valued at $16.6 billion in 2021, and is estimated to reach $28.5 billion by 2031, growing at a CAGR of 5.9% from 2022 to 2031.
โก๏ธ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ & ๐๐๐ : https://www.alliedmarketresearch.com/request-sample/16708
Vegan cosmetics are made up of chemical compounds taken from natural or synthetic sources that do not contain anyโฆ
Astrology Market Accelerate at 5.7% CAGR , USD 22.8 billion Incremental Growth
According to the report published by Allied Market Research, the global astrology market has witnessed growth valued at $12.8 billion in 2021, and is projected to reach $22.8 billion by 2031, registering a CAGR of 5.7% from 2023 to 2032. This report analyses the market dynamics, futuristic trends & developments, and segmentation overview.
โก๏ธ๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ & ๐๐๐ : https://www.alliedmarketresearch.com/request-sample/32229
โข Online Platforms and mobile apps provide wider access
Technology makes astrologyโฆ
More Releases for Erythropoietin
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view theโฆ
Global Erythropoietin Drugs Market: Segmentation
The global erythropoietin drugs market has been projected in a report by Transparency Market Research (TMR) to witness a rising focus on product development adopted by prominent companies operating in the industry. Players could be persuaded to search for new distributors due to the escalating level of competition in the market. For the purpose of earning an improved return of investment (ROI), players have been predicted to set their focusโฆ
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms ofโฆ
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports.
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered toโฆ
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development ofโฆ
Global Erythropoietin Market Research Report 2017
This report studies Erythropoietin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Erythropoietin in these regions, from 2011 toโฆ
